Listed

Creative Medical Technology Holdings, Inc.: Form 10-K for the period ended Dec 31, 2017

Filed with the SEC on Mar 29, 2018 and accepted by EDGAR at Mar 29, 2018, 16:25 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2017-01-01 to 2017-12-31$4.8kus-gaap:Revenues
Cost of revenue12 months2017-01-01 to 2017-12-31$8.0kus-gaap:CostOfRevenue
Gross profit12 months2017-01-01 to 2017-12-31−$3.2kus-gaap:GrossProfit
Research and development12 months2017-01-01 to 2017-12-31$260.1kus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2017-01-01 to 2017-12-31−$1.2mus-gaap:OperatingIncomeLoss
Interest expense12 months2017-01-01 to 2017-12-31$377.6kus-gaap:InterestExpense
Income tax12 months2017-01-01 to 2017-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income12 months2017-01-01 to 2017-12-31−$2.7mus-gaap:NetIncomeLoss
Diluted EPS12 months2017-01-01 to 2017-12-31−$0.03us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2017-01-01 to 2017-12-31−$889.6kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2017-12-31$13.7kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-12-31$18.5kus-gaap:AssetsCurrent
Total assetsAt period end2017-12-31$203.1kus-gaap:Assets
Current liabilitiesAt period end2017-12-31$2.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-12-31$2.4mus-gaap:Liabilities
Long-term debtAt period end2017-12-31$493.3kus-gaap:LongTermDebt
Shareholders' equityAt period end2017-12-31−$2.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-18-017967. Last ingested by Listed: Nov 14, 2026, 19:08 ET. Listed shows no prices and gives no investment advice.